MedPath

AURO-TRANDOLAPRIL

AURO-TRANDOLAPRIL

Approved
DIN Number

02471868

Drug Class

Human

Market Date

Sep 27, 2018

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02471868
AIG Number0131524001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09AA10 TRANDOLAPRIL
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRANDOLAPRILActive
Strength: 0.5 MG
Monograph: TRANDOLAPRIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.